Next Phase Newsletter

By Karen Deyo, Senior Investor Research Analyst, LSN

For RESI San Francisco, LSN introduced the new Featured Company Pitch Session, an opportunity for companies to register to pitch at RESI San Francisco. There was an overwhelming response, with over 150 applications for the limited spots available. The morning sessions are focused on companies in therapeutics, medical devices and advanced platforms and tools, plus a session sponsored by Dayli Partners featuring their most innovative portfolio companies. In the afternoon, Global Family Office Bioforum will lead three focused sessions on Alzheimer’s Diagnosis & Treatments, Cancer Diagnostics, and Women CEOs.  All these sessions will take place in RESI’s theatre on the 2^nd floor of Marines’ Memorial Club & Hotel.  Make sure to block off time on your schedule at RESI San Francisco to see these companies pitch!

By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

It’s challenging to raise an early stage financing round.  You need to build strong marketing collateral, and only then launch an outbound financing campaign. And then, you face the challenge of how to measure the effectiveness of the myriad partnering events you might attend during your campaign.  How does a scientist-entrepreneur gauge how a meeting went and what are the metrics they should use?  When running a fundraising campaign executives need to be vigilant in ranking which meetings were successful and may lead to further dialogue.  One learning milestone for all fundraising CEOs is being diligent about which players stay on the list and which ones are removed because of lack of interest or lack of fit.

LSN’s RESI Conference Series offers attendees a partnering system with a built in “matching algorithm” that will parse all the investors and recommend with which investors the companies should try and connect. The algorithm is based on the investor’s criteria in terms of product, stage of development, and other key parameters.  When a company gives a pitch at RESI Conference to an investor audience or meets an investor in a one-on-one meeting, they are pitching to potential partners that are a fit for them.  Typically at other partnering venues, up to half of the thirty minute meeting is trying to determine “who is selling who” and what the person on the other side of the table is seeking.  RESI Partnering has eliminated that downside.

Many conferences have partnering as a “me too” segment, as opposed to RESI, which is a dedicated partnering conference; all the partners at RESI have been screened for fit and vetted to ensure they are active investors with current investment mandates in order to comply with RESI’s investor pass program.  Another distinct feature when you attend a RESI conference is that investors can also be identified by the red ribbons on their badges!

Here are some important metrics to consider:

–Fit. This is the most important metric in meetings.  Did a company meet a potential partner that was a fit for their stage of development and product?

–Did the investor want to have a follow-up meeting?

-Did they express interest in signing an NDA?

-Did they refer you to other peers, colleagues or investors?

-Did they take the time to engage you at other times during the networking activities and receptions?

These metrics are what determines  “success” at a partnering event.  By using the information gathered by LSN’s Investor Research team fundraising executive and investors are more efficient and as a result have much more compelling meetings. With the possibility of booking up to 16 meetings at each RESI event, a scientist-entrepreneur attending RESI’s regular US and international events can connect with investors that are a good fit on a global level.  As fundraising is a numbers game, good meetings that are a fit  are the key to your company’s success.

By Claire Jeong, Director of Research, Asia BD, LSN

LSN is busily preparing for our largest conference of the year, RESI San Francisco, during JPM week on Tuesday, January 14^th, 2020. In our last RESI SF conference, we had over 1,200 attendees join, making it our largest conference to date.

This time, we are featuring 3 tracks of panels and workshops that encompass a wide variety of sectors within life science and healthcare, including more specialized topics relevant to current industry trends. For the very first time, we are also dedicating an entire track for Featured Company Pitch Sessions, which will be a valuable opportunity for companies to showcase their technologies.

The ultimate goal of our panels and workshops is to provide valuable insights to fundraising early-stage companies, especially on how groups can effectively seek to work with investors and strategic partners. RESI strives to feature industry players from large VCs to new funds, from large corporations to angel investors, to lend their expertise to the entrepreneurs attending RESI. With excellent returning speakers and many new contributors, the panel lineup at this RESI is sure to be one of the best we’ve had.

For those who are already registered for RESI, we highly encourage you to attend some panels that are relevant to your company’s interests. If you’re interested in hearing from and meeting active industry experts, but haven’t registered, it’s not too late!

Without further ado, here are some of the panelists who will be joining our panels and workshops at RESI San Francisco:

Chris Haskell VP, Head Open Innovation Center – North America West Bayer	Joyce Chan Director of External R&D Amgen	Anne Wellington Managing Director Cedars-Sinai Health Accelerator	Richard Proscia Senior Associate Providence Ventures
Brent Stackhouse Managing Director Mount Sinai Ventures	Wei Wu Senior Associate Illumina Ventures	Mike Ryan Co-Founder & CEO Bullet Point Network	Brent Ahrens General Partner Canaan Partners
Christina Takke Co-Founder & Managing Partner V-Bio Ventures	Roel Bulthuis Managing Director INKEF Capital	Claudia Karnbach Head of Business Development & Licensing, Oncology Bayer	David Cruikshank Partner ARCH Venture Partners
Dani Bach Partner +ND Capital	Bill Hyun Venture Partner Genoa Ventures	Chihiro Hosoya BD/VC Head Astellas Rx+ Business Accelerator	Ronald Dorenbos Head, Innovation Management & Scouting Takeda
Nicholas Mourlas Senior Director, New Ventures Johnson & Johnson	Gerry Brunk Managing Director Lumira Ventures	Neil Swami Principal Catalyst Health Ventures	Z Haroon Chairman and General Partner Julz Co LLC
Lauren Tyra Principal Scientist Green Park & Golf Ventures	Kwame Ulmer Venture Partner Wavemaker Three-Sixty Health	Diana Saraceni Founder and Managing Partner Panakes Partners	Ted Driscoll Managing Partner DigitalDx Ventures
Noel Jee Senior Associate Illumina Ventures	Sharon Chan Head of JLABS @Shanghai Johnson & Johnson	Weiyong Sun Senior Director, Specialty Medicine Search & Evaluation, Global Business Development Daiichi Sankyo	Lu Han Director of Business Development, Asia Pacific Lumira Ventures
Yao Li Ho Senior Director of Business Development LYFE Capital	Yanghuan Bao Investment Partner BOHE Angel Fund	Michelle Gon Partner McDermott Will & Emery Shanghai Offices	David Xu Chief Business Officer Viva Biotech
Frank Yan Operating Partner 3E Bioventures	Elona Baum Managing Director DEFTA Partners	Tad Weems Managing Director, Early Stage Partnerships Agilent Technologies	Jiwon Huh Director of Corporate Strategy Boryung Holdings
Lu Zhang Founder & Managing Partner Fusion Fund	Xinhong Lim Director Vickers Venture Partners	Yizhen Dong Principal 11.2 Capital	Miraj Sanghvi Principal DigiTx Partners

By Bryanna Allison, Business Development Manager, LSN

If you’ve registered for RESI San Francisco, then it’s likely that your goal is to book a strong slate of meetings, followed by a full day of face-to-face meetings with investors at RESI.  Here is our advice for partnering success at RESI:

• Fill out your profile! This will provide investors with information above and beyond what you can fit in your intro message. If you fill out the key fields in your profile, attendees can revert back there for more information.
• Use the filters in the sidebar when searching for meeting partners! Whether you are a startup, investor or service provider, the filters are in place to make your lives easier. You can pick a category of attendees to search, then use the filters to narrow down to the most relevant fits for you, such as investors who are interested in your sector.
• Send as many relevant meeting requests as possible. Always use the “book a meeting” option for initial contact.
• Put effort into the message you are sending along with your meeting requests. Tell them what you’re doing, who you are, why you’d be a great fit to work together and what you’re looking to get out of the relationship. Keep it concise, but informative!
• Follow up on your requests. You can use the “send a message” option in RESI Partnering to send follow-up notes, or if you have the investor’s contact info you could send an email directly.
• Continue to check the platform regularly. New investors, startup and service provider attendees are added every day. If you want to focus on newly added profiles, you can change the order of search results from ‘Order alphabetically’ to ‘Order by date approved’ and look at who’s joined since your last visit.
• Join our partnering tutorials so you can see it all firsthand! Please visit our website for the complete partnering tutorial schedule.
• Bring your partnering schedule to RESI – either print it out or have it available on your phone.

Using the partnering platform effectively can help you make the most out of RESI! It’s there so you know exactly who is coming and exactly who you need to talk to. Don’t miss out on our largest event of the year and this excellent opportunity to network with over 500 life science investors.

By Candice He, Global Investment Strategist, LSN

As a co-organizer of RESI Shanghai, Enmore has become a valuable partner of Life Science Nation, utilizing their expertise in the local market and as conference organizers to make RESI a success, with more than 450 investors, startups and service providers in attendance. LSN and Enmore have a common goal of creating an international ecosystem for advancing life science technologies to market in a global economy, and will continue to partner to achieve this. For those interested in exploring the China market and establishing relationships with key players in the China life science ecosystem, we invite you to attend the Enmore Bio Conference, taking place at the Suzhou International Expo Center from February 20-22, 2020.

What is EBC?

Enmore Bio Conference (EBC) is the largest and most influential bio-industry conference in China, as well as the most open conference platform jointly created by Enmore Healthcare, the organizer, and many industry associations, institutions, companies and experts for the whole industry chain.

EBC consists of four parallel conferences: the 10^th Antibody Drugs & Novel Biological Summit, the 8^th Molecular Diagnostics Summit, the 6^th Immunotherapy Industry Summit, and the 3^rd 17TALK Healthcare Investment & Financing Leadership Forum. The four-in-one event covers topics concerning the whole industry chain of diagnosis, treatment and medication, and other topics like CDx, target development, clinical research and policy discussion will also be touched through a dozen of special forums. The Enmore Bio Exhibition, as part of this event, will attract more than 200 suppliers of instruments, consumables and services. The EBC, which combines conference and exhibition, has become a benchmark platform for high-level exchanges and cooperation in the bio-industry in China and abroad.

Conference website: http://ebc.enmorebiz.com/english.html

Why choose EBC?

EBC is committed to building China’s largest and most influential bio industry event through four parallel conferences, a dozen of co-organized forums, three invited-only meetings for CEOs and pre-event business visits. More than 150 enterprise leaders and experts will make presentations during this event.

Previous reports of EBC:

https://mp.weixin.qq.com/s/h1YQvgaOpClaYRUmNFAmdg

http://ebc2019.enmorebiz.com

Co-organizations of EBC 2020

Guangzhou KingMed Diagnostics Group Co., Ltd.

PersonGene

Wuhan Tongji Hospital

Renmin Hospital Of Wuhan University

Shanghai Junshi Biosciences Co., Ltd.

Hengrui Medcine

Innoforce Pharmaceuticals Co., Ltd.

TOT Biopharm

SAPA-China

Everbright Medical & Healthcare Fund

EBC parallel conferences:

10^th Antibody Drugs & Novel Biological Summit

The 10^th Antibody Drugs & Novel Biological Summit is co-organized by Junshi Biosciences, Hengrui Medicine, Innoforce Pharmaceuticals, TOT BIOPHARM and SAPA-China. It covers the whole process of early research and development, process development, mass production, industrialization and commercialization. We will bring together CEOs and top leaders of functional departments of local listed companies, as well as heads of R&D, production, quality, process and business of antibody enterprises at home and abroad through a platform of exchanges and cooperation for thousands of people.

8^th Molecular Diagnostics Summit

The 8^th Molecular Diagnostics Summit is co-organized by Enmore and KingMed Diagnostics. This time we focus on “molecular diagnostics market structure and corporate strategy”, “multi-platform detection technology for clinical diagnosis” and “to create competitive molecular diagnostic products”. Authoritative experts in precision medicine and outstanding enterprises such as Jiangsu Center for Clinical Laboratories, Shanghai Center for Clinical Laboratory, Berry Genomics, Geneseeq, and KingMed Diagnostics Group will participate in this summit. An invited-only CEO meeting will happen during the summit, organized by Clinical Laboratories leaders.

6^th Immunotherapy Industry Summit

The 6^th Immunotherapy Industry Summit aims to provide businesses with the industrialization of cellular immunotherapy in the next two years. The forum is jointly developed by experts and scholars in the field of cellular immunotherapy study, quality control leaders of first-tier companies, and CEOs of domestic and foreign companies with extensive industrialization experience! Companies and institutions involved include Fosun Kite Biotechnology Co., Ltd, JW Therapeutics, Cellular Biomedicine Group, PersonGene, Tongji Hospital, etc.

3^rd 17TALK Healthcare Investment & Financing Leadership Forum

The 3^rd 17TALK Healthcare Investment & Financing Leadership Forum is co-hosted by Enmore Healthcare and Everbright Medical & Healthcare Fund. The forum features healthcare investment trends and corporate listing, inviting local and international top investors to participate in the discussions. Special financing roadshows will be held to provide a financing platform for enterprises.

Who will attend EBC?

EBC 2019 attracted 2,208 attendees, and EBC 2020 is expected to exceed 3,000 attendees. The participating groups include entrepreneurs, scientists, clinicians, investors and suppliers, mostly CEOs and heads of R&D, production, quality, process and commercialization.

Part of EBC 2019 attendees

Conference Agenda of EBC 2020

Registration at EBC

Online registration:https://ienmore.com/enmoreweb/pc/index.html?language=1&activityId=1267

Consultation: healthcare@enmore.com

By Bryanna Allison, Business Development Manager, LSN

Mark your calendar for Monday, December 9^th. The partnering portal for RESI San Francisco will launch around 11am EST! First things first, are you registered for the conference? You will only have access to the partnering portal after you have registered. If you haven’t, please don’t wait!  It’s an advantage to be in partnering at launch in order to get the first touch out to investors.

The RESI Conference was designed as a partnering conference to ensure every one of your meetings is worthwhile, based on a strong fit between company and investor.  RESI Partnering provides fully tagged profiles of all the investors attending, based on interview conducted by LSN’s Investor Research team.  Our RESI Premier Partnering attendees can also see in depth profiles on investor technology interests and get direct contact with investors.  Would you like to meet with these investors, and more?  Sign up for RESI now.

CONFIRMED RESI SAN FRANCISCO INVESTORS AND STRATEGIC PARTNERS

As of Dec. 3rd, 2019